Hrt Financial LP Chimerix Inc Transaction History

Hrt Financial LP

$17 Billion
Q2 2024

A detailed history of Hrt Financial LP transactions in Chimerix Inc stock. As of the latest transaction made, Hrt Financial LP holds 14,307 shares of CMRX stock, worth $13,877. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,307

Holding current value

$13,877

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.87 - $1.05 $12,447 - $15,022	14,307 New	14,307 $12,000
Q4 2023 Feb 09, 2024	BUY	$0.9 - $1.06 $24,332 - $28,658	27,036 New	27,036 $26,000
Q2 2023 Aug 11, 2023	BUY	$1.1 - $1.54 $91,741 - $128,437	83,401 New	83,401 $100,000
Q4 2022 Feb 10, 2023	SELL	$1.67 - $2.35 $317,004 - $446,084	-189,823 Reduced 75.23%	62,510 $116,000
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $339,355 - $517,469	-187,489 Reduced 42.63%	252,333 $487,000
Q2 2022 Aug 12, 2022	BUY	$1.34 - $5.34 $542,691 - $2.16 Million	404,994 Added 1162.84%	439,822 $914,000
Q1 2022 May 16, 2022	BUY	$4.58 - $6.8 $159,512 - $236,830	34,828 New	34,828 $159,000
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $417,835 - $573,624	-79,892 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $474,558 - $699,055	79,892 New	79,892 $494,000
Q1 2019 May 14, 2019	SELL	$1.79 - $3.12 $28,208 - $49,168	-15,759 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$2.24 - $3.9 $35,300 - $61,460	15,759 New	15,759 $40,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account